• Je něco špatně v tomto záznamu ?

Obesity II: Establishing causal links between chemical exposures and obesity

JJ. Heindel, S. Howard, K. Agay-Shay, JP. Arrebola, K. Audouze, PJ. Babin, R. Barouki, A. Bansal, E. Blanc, MC. Cave, S. Chatterjee, N. Chevalier, M. Choudhury, D. Collier, L. Connolly, X. Coumoul, G. Garruti, M. Gilbertson, LA. Hoepner, AC....

. 2022 ; 199 (-) : 115015. [pub] 20220405

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, přehledy, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22018514

Grantová podpora
R01 ES031139 NIEHS NIH HHS - United States
P30 ES025128 NIEHS NIH HHS - United States
P30 ES030283 NIEHS NIH HHS - United States
PTF155981 CIHR - Canada
R15 ES026791 NIEHS NIH HHS - United States
P30 ES005022 NIEHS NIH HHS - United States
P01 ES028942 NIEHS NIH HHS - United States
R21 ES030786 NIEHS NIH HHS - United States
T32 ES011564 NIEHS NIH HHS - United States
R21 ES031510 NIEHS NIH HHS - United States
R01 ES032189 NIEHS NIH HHS - United States
P20 GM103641 NIGMS NIH HHS - United States
R01 MH123544 NIMH NIH HHS - United States
P30 ES027792 NIEHS NIH HHS - United States
R01 ES028879 NIEHS NIH HHS - United States
R15 ES026370 NIEHS NIH HHS - United States
R35 ES028373 NIEHS NIH HHS - United States
P42 ES023716 NIEHS NIH HHS - United States
P01 AT003961 NCCIH NIH HHS - United States
R01 ES023316 NIEHS NIH HHS - United States
R21 ES030884 NIEHS NIH HHS - United States
R00 ES030405 NIEHS NIH HHS - United States

Obesity is a multifactorial disease with both genetic and environmental components. The prevailing view is that obesity results from an imbalance between energy intake and expenditure caused by overeating and insufficient exercise. We describe another environmental element that can alter the balance between energy intake and energy expenditure: obesogens. Obesogens are a subset of environmental chemicals that act as endocrine disruptors affecting metabolic endpoints. The obesogen hypothesis posits that exposure to endocrine disruptors and other chemicals can alter the development and function of the adipose tissue, liver, pancreas, gastrointestinal tract, and brain, thus changing the set point for control of metabolism. Obesogens can determine how much food is needed to maintain homeostasis and thereby increase the susceptibility to obesity. The most sensitive time for obesogen action is in utero and early childhood, in part via epigenetic programming that can be transmitted to future generations. This review explores the evidence supporting the obesogen hypothesis and highlights knowledge gaps that have prevented widespread acceptance as a contributor to the obesity pandemic. Critically, the obesogen hypothesis changes the narrative from curing obesity to preventing obesity.

Brody School of Medicine East Carolina University Greenville NC 27834 USA

Center for Environmental Health Sciences Mississippi State University Mississippi State MS 39762 USA

Clinical Epidemiology Department of Medical Sciences Uppsala University Hospital Uppsala University Uppsala Sweden

College of Health and Medicine Australian National University Canberra Australia

College of Pharmacy Texas A and M University College Station TX 77843 USA

Department of Animal Science School of Environmental and Biological Science Rutgers University New Brunswick NJ 08901 USA

Department of Biochemistry University of Paris INSERM T3S 75006 Paris France

Department of Cytokinetics Institute of Biophysics of the Czech Academy of Sciences Brno Czech Republic

Department of Developmental and Cell Biology University of California Irvine Irvine CA 92697 USA

Department of Endocrinology University of Bari Aldo Moro Bari Italy

Department of Environmental and Occupational Health Sciences School of Public Health SUNY Downstate Health Sciences University Brooklyn NY 11203 USA

Department of Epidemiology The University of North Carolina at Chapel Hill Chapel Hill NC 27599 USA

Department of Life and Health Sciences University of Bordeaux INSERM Pessac France

Department of Physiology and Pharmacology Karolinska Institute Solna Sweden

Department of Preventive Medicine and Public Health University of Granada Granada Spain

Department of Systems Biology and Bioinformatics University of Paris INSERM T3S Paris France

Division of Biological Sciences The University of Missouri Columbia MO 65211 USA

Division of Endocrinology Department of Pediatrics University of California San Francisco CA 94143 USA

Division of Endocrinology Diabetes and Metabolism The University of Illinois at Chicago Chicago Il 60612 USA

Division of Gastroenterology Hepatology and Nutrition University of Louisville Louisville KY 40402 USA

Environmental Health and Disease Laboratory University of South Carolina Columbia SC 29208 USA

Health and Environment Research Lab The Azrieli Faculty of Medicine Bar Ilan University Israel

Healthy Environment and Endocrine Disruptor Strategies Commonweal Bolinas CA 92924 USA

Institute of Environmental Health Sciences and Department of Pharmacology Wayne State University Detroit MI 48202 USA

McMaster University Department of Obstetrics and Gynecology Hamilton Ontario CA USA

Norris Cotton Cancer Center Department of Molecular and Systems Biology Geisel School of Medicine at Dartmouth Lebanon NH 03756 USA

Obstetrics and Gynecology University of Cote d'Azur Cote d'Azur France

Occupational and Environmental Health Research Group University of Stirling Stirling Scotland

Occupational and Environmental Medicine Department of Medical Sciences Uppsala University Hospital Uppsala University Uppsala Sweden

Sorbonne Paris Nord University Bobigny INSERM U1124 Paris France

The Institute for Global Food Security School of Biological Sciences Queen's University Belfast Northern Ireland UK

Univ Rennes INSERM EHESP IRSET UMR_5S 1085 35000 Rennes France

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018514
003      
CZ-PrNML
005      
20220804134826.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.bcp.2022.115015 $2 doi
035    __
$a (PubMed)35395240
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Heindel, Jerrold J $u Healthy Environment and Endocrine Disruptor Strategies, Commonweal, Bolinas, CA 92924, USA. Electronic address: jerryheindel@gmail.com
245    10
$a Obesity II: Establishing causal links between chemical exposures and obesity / $c JJ. Heindel, S. Howard, K. Agay-Shay, JP. Arrebola, K. Audouze, PJ. Babin, R. Barouki, A. Bansal, E. Blanc, MC. Cave, S. Chatterjee, N. Chevalier, M. Choudhury, D. Collier, L. Connolly, X. Coumoul, G. Garruti, M. Gilbertson, LA. Hoepner, AC. Holloway, G. Howell, CD. Kassotis, MK. Kay, MJ. Kim, D. Lagadic-Gossmann, S. Langouet, A. Legrand, Z. Li, H. Le Mentec, L. Lind, P. Monica Lind, RH. Lustig, C. Martin-Chouly, V. Munic Kos, N. Podechard, TA. Roepke, RM. Sargis, A. Starling, CR. Tomlinson, C. Touma, J. Vondracek, F. Vom Saal, B. Blumberg
520    9_
$a Obesity is a multifactorial disease with both genetic and environmental components. The prevailing view is that obesity results from an imbalance between energy intake and expenditure caused by overeating and insufficient exercise. We describe another environmental element that can alter the balance between energy intake and energy expenditure: obesogens. Obesogens are a subset of environmental chemicals that act as endocrine disruptors affecting metabolic endpoints. The obesogen hypothesis posits that exposure to endocrine disruptors and other chemicals can alter the development and function of the adipose tissue, liver, pancreas, gastrointestinal tract, and brain, thus changing the set point for control of metabolism. Obesogens can determine how much food is needed to maintain homeostasis and thereby increase the susceptibility to obesity. The most sensitive time for obesogen action is in utero and early childhood, in part via epigenetic programming that can be transmitted to future generations. This review explores the evidence supporting the obesogen hypothesis and highlights knowledge gaps that have prevented widespread acceptance as a contributor to the obesity pandemic. Critically, the obesogen hypothesis changes the narrative from curing obesity to preventing obesity.
650    _2
$a adipogeneze $7 D050156
650    _2
$a tuková tkáň $7 D000273
650    _2
$a předškolní dítě $7 D002675
650    12
$a endokrinní disruptory $x toxicita $7 D052244
650    _2
$a vystavení vlivu životního prostředí $x škodlivé účinky $7 D004781
650    _2
$a lidé $7 D006801
650    _2
$a obezita $x etiologie $7 D009765
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
655    _2
$a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Howard, Sarah $u Healthy Environment and Endocrine Disruptor Strategies, Commonweal, Bolinas, CA 92924, USA
700    1_
$a Agay-Shay, Keren $u Health and Environment Research (HER) Lab, The Azrieli Faculty of Medicine, Bar Ilan University, Israel
700    1_
$a Arrebola, Juan P $u Department of Preventive Medicine and Public Health University of Granada, Granada, Spain
700    1_
$a Audouze, Karine $u Department of Systems Biology and Bioinformatics, University of Paris, INSERM, T3S, Paris France
700    1_
$a Babin, Patrick J $u Department of Life and Health Sciences, University of Bordeaux, INSERM, Pessac France
700    1_
$a Barouki, Robert $u Department of Biochemistry, University of Paris, INSERM, T3S, 75006 Paris, France
700    1_
$a Bansal, Amita $u College of Health & Medicine, Australian National University, Canberra, Australia
700    1_
$a Blanc, Etienne $u Department of Biochemistry, University of Paris, INSERM, T3S, 75006 Paris, France
700    1_
$a Cave, Matthew C $u Division of Gastroenterology, Hepatology and Nutrition, University of Louisville, Louisville, KY 40402, USA
700    1_
$a Chatterjee, Saurabh $u Environmental Health and Disease Laboratory, University of South Carolina, Columbia, SC 29208, USA
700    1_
$a Chevalier, Nicolas $u Obstetrics and Gynecology, University of Cote d'Azur, Cote d'Azur, France
700    1_
$a Choudhury, Mahua $u College of Pharmacy, Texas A&M University, College Station, TX 77843, USA
700    1_
$a Collier, David $u Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA
700    1_
$a Connolly, Lisa $u The Institute for Global Food Security, School of Biological Sciences, Queen's University, Belfast, Northern Ireland, UK
700    1_
$a Coumoul, Xavier $u Department of Biochemistry, University of Paris, INSERM, T3S, 75006 Paris, France
700    1_
$a Garruti, Gabriella $u Department of Endocrinology, University of Bari "Aldo Moro," Bari, Italy
700    1_
$a Gilbertson, Michael $u Occupational and Environmental Health Research Group, University of Stirling, Stirling, Scotland
700    1_
$a Hoepner, Lori A $u Department of Environmental and Occupational Health Sciences, School of Public Health, SUNY Downstate Health Sciences University, Brooklyn, NY 11203, USA
700    1_
$a Holloway, Alison C $u McMaster University, Department of Obstetrics and Gynecology, Hamilton, Ontario, CA, USA
700    1_
$a Howell, George $u Center for Environmental Health Sciences, Mississippi State University, Mississippi State, MS 39762, USA
700    1_
$a Kassotis, Christopher D $u Institute of Environmental Health Sciences and Department of Pharmacology, Wayne State University, Detroit, MI 48202, USA
700    1_
$a Kay, Mathew K $u College of Pharmacy, Texas A&M University, College Station, TX 77843, USA
700    1_
$a Kim, Min Ji $u Sorbonne Paris Nord University, Bobigny, INSERM U1124 (T3S), Paris, France
700    1_
$a Lagadic-Gossmann, Dominique $u Univ Rennes, INSERM EHESP, IRSET UMR_5S 1085, 35000 Rennes, France
700    1_
$a Langouet, Sophie $u Univ Rennes, INSERM EHESP, IRSET UMR_5S 1085, 35000 Rennes, France
700    1_
$a Legrand, Antoine $u Sorbonne Paris Nord University, Bobigny, INSERM U1124 (T3S), Paris, France
700    1_
$a Li, Zhuorui $u Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA 92697, USA
700    1_
$a Le Mentec, Helene $u Sorbonne Paris Nord University, Bobigny, INSERM U1124 (T3S), Paris, France
700    1_
$a Lind, Lars $u Clinical Epidemiology, Department of Medical Sciences, Uppsala University Hospital, Uppsala University, Uppsala, Sweden
700    1_
$a Monica Lind, P $u Occupational and Environmental Medicine, Department of Medical Sciences, Uppsala University Hospital, Uppsala University, Uppsala, Sweden
700    1_
$a Lustig, Robert H $u Division of Endocrinology, Department of Pediatrics, University of California San Francisco, CA 94143, USA
700    1_
$a Martin-Chouly, Corinne $u Sorbonne Paris Nord University, Bobigny, INSERM U1124 (T3S), Paris, France
700    1_
$a Munic Kos, Vesna $u Department of Physiology and Pharmacology, Karolinska Institute, Solna, Sweden
700    1_
$a Podechard, Normand $u Sorbonne Paris Nord University, Bobigny, INSERM U1124 (T3S), Paris, France
700    1_
$a Roepke, Troy A $u Department of Animal Science, School of Environmental and Biological Science, Rutgers University, New Brunswick, NJ 08901, USA
700    1_
$a Sargis, Robert M $u Division of Endocrinology, Diabetes and Metabolism, The University of Illinois at Chicago, Chicago, Il 60612, USA
700    1_
$a Starling, Anne $u Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
700    1_
$a Tomlinson, Craig R $u Norris Cotton Cancer Center, Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA
700    1_
$a Touma, Charbel $u Sorbonne Paris Nord University, Bobigny, INSERM U1124 (T3S), Paris, France
700    1_
$a Vondracek, Jan $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic
700    1_
$a Vom Saal, Frederick $u Division of Biological Sciences, The University of Missouri, Columbia, MO 65211, USA
700    1_
$a Blumberg, Bruce $u Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA 92697, USA
773    0_
$w MED00000704 $t Biochemical pharmacology $x 1873-2968 $g Roč. 199, č. - (2022), s. 115015
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35395240 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804134820 $b ABA008
999    __
$a ok $b bmc $g 1822213 $s 1169757
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 199 $c - $d 115015 $e 20220405 $i 1873-2968 $m Biochemical pharmacology $n Biochem Pharmacol $x MED00000704
GRA    __
$a R01 ES031139 $p NIEHS NIH HHS $2 United States
GRA    __
$a P30 ES025128 $p NIEHS NIH HHS $2 United States
GRA    __
$a P30 ES030283 $p NIEHS NIH HHS $2 United States
GRA    __
$a PTF155981 $p CIHR $2 Canada
GRA    __
$a R15 ES026791 $p NIEHS NIH HHS $2 United States
GRA    __
$a P30 ES005022 $p NIEHS NIH HHS $2 United States
GRA    __
$a P01 ES028942 $p NIEHS NIH HHS $2 United States
GRA    __
$a R21 ES030786 $p NIEHS NIH HHS $2 United States
GRA    __
$a T32 ES011564 $p NIEHS NIH HHS $2 United States
GRA    __
$a R21 ES031510 $p NIEHS NIH HHS $2 United States
GRA    __
$a R01 ES032189 $p NIEHS NIH HHS $2 United States
GRA    __
$a P20 GM103641 $p NIGMS NIH HHS $2 United States
GRA    __
$a R01 MH123544 $p NIMH NIH HHS $2 United States
GRA    __
$a P30 ES027792 $p NIEHS NIH HHS $2 United States
GRA    __
$a R01 ES028879 $p NIEHS NIH HHS $2 United States
GRA    __
$a R15 ES026370 $p NIEHS NIH HHS $2 United States
GRA    __
$a R35 ES028373 $p NIEHS NIH HHS $2 United States
GRA    __
$a P42 ES023716 $p NIEHS NIH HHS $2 United States
GRA    __
$a P01 AT003961 $p NCCIH NIH HHS $2 United States
GRA    __
$a R01 ES023316 $p NIEHS NIH HHS $2 United States
GRA    __
$a R21 ES030884 $p NIEHS NIH HHS $2 United States
GRA    __
$a R00 ES030405 $p NIEHS NIH HHS $2 United States
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

    Možnosti archivace